Supporting this, studies have shown higher NMD pathway scores in MSI-H versus MSS tumors [84], while UPF1 overexpression in CRC has been linked to metastasis and inhibition of apoptosis [85] and chemoresistance to oxaliplatin [86], with implications for patient survival. Here, UPF1 is linked to colorectal carcinoma.